LYZL4 and Alzheimer disease: The ability of microglia to effectively clear Aβ may represent a determining factor in AD pathogenesis.[35, 36] Our findings suggest that modulating microglial Lyzl4 expression may prove beneficial for the treatment of AD and provide an avenue for further research on the molecular mechanisms underlying microglial involvement in Aβ clearance.